Male (n=6718) | Age group (%) | ||||
---|---|---|---|---|---|
All | 35–44 | 45–54 | 55–64 | 65–74 | |
Without CKD | |||||
eGFR≥60 and ACR<30 | 89.9 | 96.2 | 93.5 | 88.0 | 69.4 |
With CKD (overall) | 10.1 | 3.8 | 6.5 | 12.0 | 31.6 |
eGFR≥60 and ACR≥30 | 4.7 | 2.9 | 4.4 | 5.7 | 7.1 |
eGFR<60 and ACR<30 | 4.1 | 0.8 | 1.5 | 5.1 | 16.9 |
eGFR<60 and ACR≥30 | 1.3 | 0.1 | 0.6 | 1.2 | 6.6 |
Female (n=7918) | Age group (%) | ||||
All | 35–44 | 45–54 | 55–64 | 65–74 | |
Without CKD | |||||
eGFR≥60 and ACR<30 | 92.1 | 96.5 | 94.9 | 89.6 | 78.6 |
With CKD (overall) | 7.9 | 3.5 | 5.1 | 10.4 | 21.4 |
eGFR≥60 and ACR≥30 | 3.7 | 2.9 | 3.5 | 4.4 | 4.1 |
eGFR<60 and ACR<30 | 3.8 | 0.5 | 1,3 | 5,4 | 16.0 |
eGFR<60 and ACR≥30 | 0.4 | 0.1 | 0.3 | 0.6 | 1.3 |
Bold indicates results that are statistically significant at p<0.05.
ACR, albumin–creatinine ratio (mg/g); CKD, chronic kidney disease; CKD-EPI, CKD epidemiology collaboration; eGFR, glomerular filtration rate (mL/min/1.73 m2) estimated by CKD-EPI without correction for race/skin colour black; ELSA, The Brazilian Longitudinal Study of Adult Health.